Shiyi Yu
Yangzhou University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Cancer Diagnosis and Treatment, Viral-associated cancers and disorders, RNA modifications and cancer, Advanced Breast Cancer Therapies
Most-Cited Works
- → Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression(2014)67 cited
- → Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer(2017)61 cited
- → A central role for TRPS1 in the control of cell cycle and cancer development(2014)57 cited
- → CD44 promotes hepatocellular carcinoma progression via upregulation of YAP(2021)44 cited
- → Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling(2021)30 cited
- → Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer(2020)29 cited
- → LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity(2023)29 cited
- → The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer(2019)27 cited
- → ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling(2019)23 cited
- → Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice(2008)23 cited